|
SRGAP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.63090000000676E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.214200E-02 |
| Normal-vs-Stage2 |
3.800200E-02 |
| Normal-vs-Stage3 |
2.421900E-03 |
| Normal-vs-Stage4 |
3.441500E-02 |
| Stage1-vs-Stage2 |
5.316200E-01 |
| Stage1-vs-Stage3 |
2.408200E-02 |
| Stage1-vs-Stage4 |
9.092100E-02 |
| Stage2-vs-Stage3 |
1.004400E-01 |
| Stage2-vs-Stage4 |
1.603760E-01 |
| Stage3-vs-Stage4 |
7.316200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.353000E-04 |
| Normal-vs-AfricanAmerican |
1.659920E-02 |
| Normal-vs-Asian |
3.115200E-01 |
| Caucasian-vs-AfricanAmerican |
5.540600E-01 |
| Caucasian-vs-Asian |
4.440400E-01 |
| AfricanAmerican-vs-Asian |
5.545600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.782600E-03 |
| Normal-vs-Female |
7.47700000025553E-07 |
| Male-vs-Female |
4.564400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.518400E-02 |
| Normal-vs-Extreme_Weight |
4.639600E-02 |
| Normal-vs-Obese |
2.182300E-04 |
| Normal-vs-Extreme_Obese |
8.146000E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.211800E-01 |
| Normal_Weight-vs-Obese |
1.243040E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.879600E-01 |
| Extreme_Weight-vs-Obese |
1.512390E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.567000E-01 |
| Obese-vs-Extreme_Obese |
1.180400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.822500E-03 |
| Normal-vs-Age(41-60Yrs) |
3.28090000001335E-06 |
| Normal-vs-Age(61-80Yrs) |
9.366100E-02 |
| Normal-vs-Age(81-100Yrs) |
2.863600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.122300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.264300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.754150E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.024800E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.417800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.335800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.080090E-02 |
| Normal-VS-Type2 PRCC |
1.603590E-02 |
| Normal-VS-KIRP CIMP |
5.419000E-03 |
| Normal-VS-Unclassified PRCC |
1.51104999999152E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.260200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.053790E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.805500E-04 |
| Type2 PRCC-VS-KIRP CIMP |
2.445700E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.692300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.384100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.389500E-02 |
| Normal-vs-N1 |
3.557500E-04 |
| Normal-vs-N2 |
9.563900E-02 |
| N0-vs-N1 |
5.457000E-03 |
| N0-vs-N2 |
2.077700E-03 |
| N1-vs-N2 |
4.339600E-01 |
|
|
